ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,170Medicare Part D Prescriptions Filled, Including Refills

Rank: 128 out of 1171

$558K Total Retail Price of All Prescriptions

Rank: 175 out of 1171

542 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 542 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 8,024 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
OMEPRAZOLE 539 392 1 5
LEVOTHYROXINE SODIUM 390 347 2 4
LISINOPRIL 376 275 3 3
FUROSEMIDE 369 273 4 6
AMLODIPINE BESYLATE 305 247 5 2
WARFARIN SODIUM 266 243 6 12
SIMVASTATIN 250 187 7 1
CARVEDILOL 243 157 8 20
METFORMIN HCL 235 145 9 7
CITALOPRAM HBR 207 144 10 22
LOSARTAN POTASSIUM 200 156 11 14
MELOXICAM 186 126 12 56
METOPROLOL TARTRATE 186 142 12 11
TRAMADOL HCL 177 104 14 18
HYDROCODONE-ACETAMINOPHEN 157 116 S3 15 8
PRAVASTATIN SODIUM 150 113 16 13
ATORVASTATIN CALCIUM 148 131 17 10
ALENDRONATE SODIUM 145 129 18 33
ISOSORBIDE MONONITRATE ER 141 102 19 44
GABAPENTIN 141 78 19 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 96 21 26
ATENOLOL 126 103 22 15
ZOLPIDEM TARTRATE 123 75 23 21
AZITHROMYCIN 122 74 24 43
RANITIDINE HCL 122 76 24 38
LANTUS 111 83 26 46
HYDROCHLOROTHIAZIDE 110 89 27 9
SPIRONOLACTONE 109 54 28 53
LEVOFLOXACIN 103 71 29 105
METOPROLOL SUCCINATE 101 78 30 17
NEXIUM 91 47 31 25
PROAIR HFA 89 44 32 49
PANTOPRAZOLE SODIUM 85 55 33 29
TRAZODONE HCL 78 22 34 37
CRESTOR 76 61 35 27
GLIPIZIDE 74 64 36 47
LOVASTATIN 73 32 37 36
PAROXETINE HCL 72 52 38 62
DONEPEZIL HCL 71 70 39 24
CLOPIDOGREL 71 59 39 35
SERTRALINE HCL 68 37 41 23
POTASSIUM CHLORIDE 67 41 42 19
SUCRALFATE 65 52 43 182
ADVAIR DISKUS 64 36 44 51
FLUTICASONE PROPIONATE 63 44 45 30
SINGULAIR 63 32 45 78
BYSTOLIC 63 61 45 96
FLUOXETINE HCL 62 29 48 76
BENAZEPRIL HCL 61 47 49 83
DILTIAZEM HCL 61 49 49 247
LOSARTAN-HYDROCHLOROTHIAZIDE 61 52 49 40
AMITRIPTYLINE HCL 61 46 R 49 74
DIGOXIN 59 59 53 68
PREDNISONE 56 50 54 39
TRILIPIX 55 55 55 198
INSULIN SYRINGE 54 35 56 71
TAMSULOSIN HCL 53 45 57 28
KLOR-CON M20 51 49 58 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.